Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2026
Lysosomal TMEM165 remodels calcium signaling to drive hypoxia adaptation and tumor progressionYu Zeng, Meiting Chen, Yu Cao, et al.
Cell Death & Disease|July 27, 2021
HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activityWenwei Luo, Jingyan Li, Ziqing Li, et al.
Cancer Research and Treatment|October 17, 2023
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective StudyKuikui Jiang, Ruoxi Hong, Wen Xia, et al.
NPJ Breast Cancer|June 13, 2024
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasisDongshao Chen, Fei Xu, Yongkui Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Olanzapine combined with standard antiemetics for the prevention of nausea and vomiting in patients with germ cell tumor undergoing a 5-day cisplatin-based chemotherapy (NAVIGATE study)： A phase III crossover trialLulu Zhang, Meiting Chen, Qingru Zhou, et al.
The Science of the Total Environment|March 19, 2021
Ambient marine shipping emissions determined by vessel operation mode along the East China SeaYangzhou Wu, Dantong Liu, Xiaotong Wang, et al.
The Oncologist|December 5, 2025
Estradiol levels in women with hormone receptor-positive advanced breast cancer on fulvestrant therapyShuqin Dai, Yanling Wen, Xingping Wu, et al.
Cancer Medicine|April 25, 2023
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center databaseMengqian Ni, Fang Wang, Anli Yang, et al.
Cancer Medicine|May 16, 2026
Germline Pathogenic Variants in HER2-Positive Breast Cancer: Spectrum and Clinical Implications in a High-Risk Chinese CohortLijia Zhou, Mengqian Ni, Anli Yang, et al.
Research (Washington, D.C.)|July 10, 2023
Leukocyte-Specific Morrbid Promotes Leukocyte Differentiation and AtherogenesisDi Xiang, Lei Jiang, Qiong Yuan, et al.
Pageof 8